Pulmonary Embolism (PE)

Overview & Epidemiology

Pathophysiology

• Mechanical obstruction → increased RV afterload → RV dilation and dysfunction → septal shift → reduced LV preload → decreased cardiac output
• Hypoxemia: V/Q mismatch, intracardiac shunting, low mixed venous O₂ from low CO
• Pulmonary infarction (10–15%): peripheral emboli causing pleuritic pain, hemoptysis, fever
• Neurohormonal activation: release of serotonin, thromboxane A₂, histamine → vasoconstriction beyond mechanical obstruction
• RV ischemia: RV dilation increases wall tension and O₂ demand while coronary perfusion pressure drops → RV failure spiral → cardiac arrest (often as PEA)

Risk Factors

Clinical Presentation

Syncope accounts for <5% of PE presentations, but unexplained syncope in a patient with risk factors warrants evaluation. PEA is the most common rhythm in PE-related cardiac arrest. — Rosen's Emergency Medicine

Diagnosis

Step 1 — Pre-Test Probability (PTP)

• Score ≤4 = PE unlikely; >4 = PE likely

• Low (<4), Intermediate (4–10), High (>10)

Step 2 — PERC Rule (for Low PTP)

• Age <50 | Pulse <100 | SaO₂ >94% | No unilateral leg swelling | No hemoptysis | No recent trauma/surgery | No prior PE/DVT | No hormone use

Step 3 — D-Dimer

• Sensitivity 95–98%; specificity 40–55%
• A negative D-dimer excludes PE in non-high PTP patients (NPV 99–100%)
• Age-adjusted D-dimer threshold: (age × 10 μg/L in patients >50 years) increases specificity without sacrificing sensitivity
• Elevated in cancer, pregnancy, hospitalization, infection — limited utility in these groups

Step 4 — Imaging

🆕 2026 AHA/ACC PE Clinical Category System

"The old language of massive, submassive, and low-risk... is gone." — LITFL Commentary on 2026 Guidelines

Management by Category (2026 AHA/ACC)

Category A (Incidental/Asymptomatic)

• Anticoagulation is generally recommended (individualized based on thrombus burden and bleeding risk)
• Outpatient management appropriate

Category B (Low Severity)

• DOAC preferred over VKA (Class I, Level B-R) — first time explicitly stated in a US guideline
• Candidates for early discharge / outpatient treatment (Hestia criteria or simplified PESI = 0)
• LMWH preferred over UFH if initial parenteral therapy needed (Class I)

Category C (Elevated Score, Hemodynamically Stable)

• Anticoagulation (DOAC preferred)
• Consider hospital admission for monitoring
• Consider PERT activation
• Serial clinical/biomarker reassessment

Category D (Incipient Failure — D1 & D2)

• Anticoagulate (heparin preferred if advanced therapy anticipated)
• Activate PERT (Class I recommendation — upgrade from prior guidelines)
• Consider catheter-directed thrombolysis (CDT) + anticoagulation (Class 2a) to prevent deterioration
• Mechanical thrombectomy (MT) is reasonable as alternative to CDT (Class 2a)
• ICU/monitored bed admission

Category E (Established Failure/Shock)

• UFH immediately (enables rapid reversal if surgical intervention needed)
• PERT activation mandatory
• Systemic thrombolysis (tPA 100 mg over 2h) — Class I if no contraindications
• CDT + anticoagulation reasonable (Class 2a) when systemic lysis is contraindicated or fails
• Surgical embolectomy: Class 2a when thrombolysis contraindicated/failed and resources available
• VA-ECMO: reasonable in refractory shock when expertise available

Key 2026 Guideline Recommendations (Top 8)

1. DOACs over VKAs for eligible patients — Class I, Level B-R
2. LMWH over UFH for initial parenteral anticoagulation — Class I
3. PERT activation for Categories C–E — Class I (upgraded)
4. Systemic thrombolysis for Category E (established shock) — Class I
5. CDT + anticoagulation for Category D1-2 — Class 2a
6. Outpatient treatment for Category B using validated criteria (Hestia, sPESI)
7. Anticoagulation for incidental PE (Category A) — individualized
8. Minimum 3 months anticoagulation for all confirmed symptomatic PE

Anticoagulation Duration

Special Populations

Chronic Complications

• Post-PE syndrome: Exertional dyspnea, reduced exercise tolerance; occurs in 30–50%
• Chronic Thromboembolic Pulmonary Hypertension (CTEPH): ~1–4% after acute PE; requires V/Q scan for screening; managed with pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA), or riociguat
• Post-thrombotic syndrome: Chronic venous insufficiency from DVT

Summary Algorithm

Suspected PE
    ↓
Hemodynamically unstable? → YES → UFH + PERT + Thrombolysis / Thrombectomy (Category E)
    ↓ NO
Calculate PTP (Wells / Geneva)
    ↓
Low PTP → PERC negative? → No further testing
    ↓ PERC positive or Non-low PTP
D-Dimer
    ↓ Positive (or High PTP → skip D-dimer)
CTPA
    ↓ PE confirmed
Risk stratify → Biomarkers + Echo/CTPA RV assessment
    ↓
Category B: DOAC, early discharge
Category C: DOAC, admission, PERT consider
Category D: Heparin, PERT activate, CDT/MT
Category E: UFH, PERT, Systemic thrombolysis / Surgery / ECMO

Citations

• 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline — Creager MA et al. Circulation. 2026;153:e977–e1051. PMID: 41712677 | JACC PMID: 41712898
• Rosen's Emergency Medicine, 9e — Chapter 74
• Fuster and Hurst's The Heart, 15e — Chapter 58
• Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume Set

Note: The 2026 AHA/ACC guideline supersedes the 2011 AHA scientific statement and is now the primary US reference for acute PE management. The ESC 2019 guideline remains relevant in European practice. Assess individual patient bleeding risk and comorbidities before any anticoagulation or reperfusion decision.Key highlights from the 2026 AHA/ACC guideline (the first dedicated US PE guideline, published February 2026):

1. New 5-category system (A–E) replaces "massive/submassive/low-risk" — more granular, prognosis-driven classification
2. DOACs are now formally Class I (recommended over VKAs) — first explicit endorsement in a US guideline
3. PERT activation upgraded to Class I for categories C–E
4. CDT and mechanical thrombectomy given Class 2a recommendations for Category D (intermediate-high)
5. Outpatient treatment explicitly endorsed for Category B (low-severity)
6. VA-ECMO recognized as a bridging strategy in refractory Category E